Co-diagnostics, inc. to sponsor and present at molecular med tri-con 2022

Salt lake city, feb. 17, 2022 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be a premium sponsor of the upcoming molecular med tri-con held february 21-23, 2022 in san diego, ca, which will also include a presentation by representatives of the company and its newly-acquired subsidiary. co-diagnostics ceo dwight egan and dr. kirk ririe, president of the company's subsidiary, will be presenting in the conference's at-home & point-of-care diagnostics track on monday, february 21 from 12:20 pm to 12:50 pm.
CODX Ratings Summary
CODX Quant Ranking